Subscribe
Magazine
Videos
Advertise
About Us
Smart Water Summit
Wastewater Summit
Drinking Water
Smart Water
Asset Management
Water Utility Management
Water Reuse
Global Thought Leaders
Podcast
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
WaterWorld Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Relay Therapeutics, Inc.
Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights
August 06, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Announce Second Quarter 2024 Financial Results and Corporate Highlights on August 6, 2024
July 30, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Discloses Three New Programs at New Program & Platform Event
June 06, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
June 05, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PFE
RLAY
Relay Therapeutics to Participate in Upcoming Investor Conferences
May 21, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
May 13, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights
May 02, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024
April 25, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Participate in Upcoming Investor Conferences
April 11, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Participate in Three Upcoming Investor Conferences
February 26, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
February 22, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024
February 15, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 01, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Announces $30 Million Private Placement Financing
January 08, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Participate in Stifel 2023 Healthcare Conference
November 07, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Highlights
November 02, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Announce Third Quarter 2023 Financial Results and Corporate Highlights on November 2, 2023
October 26, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid Tumors
October 12, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Present Clinical Data on RLY-4008 in Advanced FGFR2-Altered Solid Tumors at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
September 18, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Highlights
August 08, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Announce Second Quarter 2023 Financial Results and Corporate Highlights on August 8, 2023
August 01, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Announces Full Dose Escalation Data for RLY-4008
May 25, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
May 24, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Reports First Quarter 2023 Financial Results and Corporate Highlights
May 04, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Announce First Quarter 2023 Financial Results and Corporate Highlights
April 27, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
April 19, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Announces Initial Clinical Data Demonstrating that RLY-2608 Selectively Targets Multiple PI3Kα Mutations
April 18, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Present Initial Clinical Data on RLY-2608 at AACR
March 06, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
March 01, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.